PartnershipApr 24, 2026, 05:16 PM
Odyssey Health closes exclusive worldwide BreastCheck™ distribution deal
AI Summary
Odyssey Health, Inc. announced the successful closing of its Master Technology and Sub-license Agreement with NeuRX Health, Inc. This agreement grants Odyssey's wholly-owned subsidiary, Odyssey Medical Devices, Inc., exclusive worldwide marketing and distribution rights for BreastCheck™, a non-invasive test for breast abnormalities. The closing, which occurred on April 21, 2026, signifies a significant step in bringing this diagnostic technology to market globally.
Key Highlights
- Closed Master Technology and Sub-license Agreement with NeuRX Health.
- Grants exclusive worldwide rights for BreastCheck™ to Odyssey Medical Devices.
- BreastCheck™ is a non-invasive test for breast abnormalities.
- Closing of the agreement occurred on April 21, 2026.